XETRA - Delayed Quote EUR
BB Biotech AG Ord (BBZA.DE)
At close: October 18 at 5:35 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Cash Flows from Used in Operating Activities Direct
104,486.00
218,276.00
231,131.00
-94,787.00
262,449.00
--
Financing Cash Flow
-105,049.00
-220,213.00
-233,271.00
91,768.00
-284,483.00
--
End Cash Position
337.00
501.00
1,948.00
2,835.00
6,816.00
--
Issuance of Capital Stock
--
--
--
9,653.00
20.00
--
Issuance of Debt
14,500.00
--
8,000.00
292,000.00
--
-35,000.00
Repayment of Debt
-3,600.00
-58,100.00
--
--
-87,000.00
-35,000.00
Repurchase of Capital Stock
--
--
-27,303.00
-9,459.00
-8,260.00
--
Free Cash Flow
104,486.00
218,276.00
231,131.00
-94,787.00
262,449.00
--
12/31/2019 - 1/17/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIO3.DE Biotest Aktiengesellschaft
27.70
0.00%
88Q.DE 4basebio PLC
16.20
0.00%
T5O0.DE bioXXmed AG
3.1500
-9.74%
BIO.DE Biotest Aktiengesellschaft
41.80
+0.48%
7V0.DE Darwin AG
31.40
+5.37%
PSH.DE Sernova Corp.
0.1748
-0.63%
AYJ.DE Valneva SE
2.6660
+4.71%
VX1.DE Vertex Pharmaceuticals Incorporated
447.30
-0.38%
HPHA.DE Heidelberg Pharma AG
2.6700
+4.71%
FYB.DE Formycon AG
52.90
+1.73%